Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Recruiting

Methods of T Cell Depletion Trial (MoTD)

NCT04888741

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations
  • University Hospital of Wales Cardiff, Wales, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
View all 17 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

NCT06313593

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • The University of Alabama At Birmingham Birmingham, Alabama, United States
  • Stanford University Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 30 locations
View Trial Details
Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

NCT04176198

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
View all 84 locations
View Trial Details
Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

NCT06517875

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • GSK Investigational Site Ann Arbor, Michigan, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Houston, Texas, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

NCT06034002

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Miami Health System Miami, Florida, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details

Related conditions